Aerovate Therapeutics, Inc. (AVTE)

Aerovate Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	31.07	23.49	22.4	54.2	4.57	3.51
Short-Term Investments	73.13	98.95	106.82	113.18	-	-
Cash & Short-Term Investments	104.2	122.44	129.22	167.38	4.57	3.51
Cash Growth	-30.58%	-5.25%	-22.80%	3560.07%	30.14%	-
Prepaid Expenses	6.11	1.54	1.98	6.72	0.07	-
Other Current Assets	0.45	0.25	0.3	0.24	0.04	-
Total Current Assets	110.76	124.23	131.5	174.33	4.68	3.51
Property, Plant & Equipment	0.85	0.9	1.25	0.73	0.04	-
Other Long-Term Assets	0.08	2.28	2.56	0.3	-	-
Total Assets	111.69	127.42	135.3	175.36	4.72	3.51
Accounts Payable	4.18	2.4	2.58	1.21	0.61	0.54
Accrued Expenses	11.7	13.73	4.44	1.01	1.14	0.11
Current Portion of Leases	0.48	0.42	0.39	0.19	-	-
Other Current Liabilities	0.67	1.09	0.38	0.14	0.02	0
Total Current Liabilities	17.02	17.64	7.78	2.55	1.77	0.66
Long-Term Debt	-	-	-	-	-	2.5
Long-Term Leases	0.21	0.26	0.71	0.38	-	-
Other Long-Term Liabilities	0.07	0.07	0.07	0.01	-	-
Total Liabilities	17.3	17.96	8.56	2.95	1.77	3.16
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	305.86	272.64	215.11	208.87	0.06	-
Retained Earnings	-211.39	-163.42	-87.9	-36.39	-13.41	-3.64
Comprehensive Income & Other	-0.08	0.24	-0.47	-0.06	-	-
Total Common Equity	94.4	109.46	126.74	172.42	-13.34	-3.64
Shareholders' Equity	94.4	109.46	126.74	172.42	2.94	0.36
Total Liabilities & Equity	111.69	127.42	135.3	175.36	4.72	3.51
Total Debt	0.68	0.68	1.09	0.57	-	2.5
Net Cash (Debt)	103.52	121.76	128.13	166.8	4.57	1.01
Net Cash Growth	-30.64%	-4.97%	-23.18%	3547.52%	350.99%	-
Net Cash Per Share	3.68	4.62	5.24	13.57	18.88	4.20
Filing Date Shares Outstanding	28.87	27.86	24.81	24.41	0.24	0.24
Total Common Shares Outstanding	28.85	27.76	24.72	24.41	0.24	0.24
Working Capital	93.74	106.6	123.71	171.78	2.9	2.86
Book Value Per Share	3.27	3.94	5.13	7.06	-54.90	-15.09
Tangible Book Value	94.4	109.46	126.74	172.42	-13.34	-3.64
Tangible Book Value Per Share	3.27	3.94	5.13	7.06	-54.90	-15.09

Source: S&P Capital IQ. Standard template. Financial Sources.